The Wide Spectrum of Next-Generation Sequencing Assays with VarSeq

varseq Logo

About this webinar

April 26, 2023 // 12:00 PM EST

Presented By: Darby Kammeraad & Jennifer Dankoff

In this recorded webcast, you will explore the compelling reasons for laboratories to implement their entire next-generation sequencing (NGS) pipeline in-house, particularly for clinical applications where validating routine diagnostics is crucial for delivering accurate genetic results to patients. The NGS pipeline, which consists of multiple stages, is highly automatable. However, geneticists often spend the most time on the tertiary stage, where they must comb through vast amounts of genetic variants to identify and report those most pertinent to patients or populations.

Regrettably, the tertiary stage can be quite complex, and there is a scarcity of comprehensive and straightforward tools available on the market. Many existing tools face limitations in handling large-scale genomic data or designing various NGS assays. Additionally, their licensing models may be based on individual samples, creating cost-benefit challenges for users as sample loads inevitably grow.

Thankfully, these assay and cost-related concerns are not applicable to Golden Helix products. This webcast aims to showcase the flexibility that GHI VarSeq offers in building your ideal NGS assay. The demonstration covers germline and somatic workflows for single and multi-sample analysis across a range of disorders. Watch the webcast to discover the extensive analytical possibilities achievable with VarSeq software.

Watch on demand

Please enjoy this webcast recording. Should you have any questions about the content covered, please reach out to our team here.

Download the slide deck

To download a copy of the slides, click on the LinkedIn icon. This will redirect you to the SlideShare site. From there, you can clip your favorite slides or download the entire deck to your computer.

Love this webcast? Check out more!

Find out how Golden Helix software enables users to harness the full potential of genomics to identify the cause of disease, improve the efficacy and safety of drugs, develop genomic diagnostics, and advance the quest for personalized medicine.